A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sickle cell anemia is caused by homozygosity of the beta-S (βS) allele (located on chromosome 11p15.5), which differs from the wild-type β-allele by a single nucleotide polymorphism dbSNP Rs334(T;T) in which GTG is substituted for GAG in the sixth codon of the β-globin gene (1, 3, 5, 6).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [5]
Citations
Cites
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
The free amino groups of haemoglobins
Porter, R., & Sanger, F. (1948) · Biochemical Journal · doi:10.1042/bj0420287 · Cited by 382
The Inheritance of Sickle Cell Anemia
Neel, J. V. (1949) · Science · doi:10.1126/science.110.2846.64 · Cited by 360
�ber Papierionophorese bei Spannungsgef�llen von 50 Volt/cm
Michl, H. (1951) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00900846 · Cited by 253
State of Hæmoglobin in Sickle-Cell Anæmia
PERUTZ, M. F., & MITCHISON, J. M. (1950) · Nature · doi:10.1038/166677a0 · Cited by 221
X-Ray and Solubility Studies of the Hæmoglobin of Sickle-Cell Anæmia Patients
PERUTZ, M. F., LIQUORI, A. M., & EIRICH, F. (1951) · Nature · doi:10.1038/167929a0 · Cited by 187
Sulphydryl groups in haemoglobins
Ingram, V. M. (1955) · Biochemical Journal · doi:10.1042/bj0590653 · Cited by 94
Self-citationAMINO ACID COMPOSITION OF HEMOGLOBINS OF NORMAL NEGROES AND SICKLE-CELL ANEMICS
Schroeder, W. A., Kay, L. M., Wells, I. C., Gerke, C., & Moss, J. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50947-4 · Cited by 67
Amino-Acid Composition of Four Different Kinds of Human Hæmoglobin
Huisman, T. H. J., Jonxis, J. H. P., & Schaaf, P. (1955) · Nature · doi:10.1038/175902a0 · Cited by 34
The sulfhydryl groups of four different human haemoglobins
Hommes, F. A., Santema-Drinkwaard, J., & Huisman, T. H. J. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90358-4 · Cited by 25
Cited by
Items 301–400 of 894
Gene therapy for sickle cell disease: recent advances, clinical trials and future directions
Ballantine, J., & Tisdale, J. F. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.11.006 · Cited by 42
Meher, S., Patel, S., Das, K., Dehury, S., Jit, B. P., Maske, M. M., Das, P., Dash, B. P., & Mohanty, P. K. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03776-x · Cited by 23
Liu, J., Wang, T., Xiong, L., Xue, L., Al‐Hawwas, M., Huang, J., Niu, R., Tan, Y., Xu, Y., & Su, Y.-Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264469 · Cited by 23
“A variety of human diseases, including sickle-cell anemia, β-thalassemia and cystic fibrosis are correlated with SNPs (Ingram, 1956; Chang and Kan, 1979; Hamosh et al., 1992).”
Sequence Variants and Sequence Variant Analysis in Biotherapeutic Proteins
Borisov, O. V., Alvarez, M., Carroll, J. A., & Brown, P. W. (2015) · ACS symposium series · doi:10.1021/bk-2015-1201.ch002 · Cited by 23
Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease
Ansari, J., Moufarrej, Y. E., Pawliński, R., & Gavins, F. N. E. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1407240 · Cited by 27
“The disease itself was first reported by Herrick in 1910 [1], with the molecular defect being discovered by Pauling and Itano in 1949 [2], and further described and characterized by Ingram [3] almost six decades ago.”
BackgroundIncreased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy
da Cruz, P. R. S., Lira, R. P. C., Filho, S., de Souza, B. B., Mitsuushi, F. N., Menaa, F., Fertrin, K. Y., de Vasconcellos, J. P. C., Conran, N., Costa, F. F., et al. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.08.003 · Cited by 25
Creager, A. N. H. (1999) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/s1369-8486(99)00017-5 · Cited by 22
de’Angelis, N., Abdalla, S., Carra, M. C., Lizzi, V., Martínez‐Pérez, A., Habibi, A., Bartolucci, P., Galactéros, F., Laurent, A., & Brunetti, F. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5925-y · Cited by 21
“SCD refers to all genotypes containing at least one sickle gene, including homozygous SCA (HbSS) and compound heterozygotes for hemoglobin S and C (HbSC) or hemoglobin S and β thalassemia (HbSβThal) [4, 5].”
BackgroundRothberg, S., Crounse, R. G., Davis, L., Avogardo, L., & Lamas, J. (1965) · Journal of Investigative Dermatology · doi:10.1038/jid.1965.56 · Cited by 21
Alternative diaspirins for modification of hemoglobin and sickle hemoglobin
Delaney, E. J., Massil, S. E., Shi, G., & Klotz, I. M. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90032-8 · Cited by 21
Helical crystallization on lipid nanotubes: Streptavidin as a model protein
DANG, T., Farah, S. J., Gast, A. P., Robertson, C. R., Carragher, B. O., Egelman, E. H., & Wilson-Kubalek, E. M. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.02.002 · Cited by 21
In vitro exposure to hydroxyurea reduces sickle red blood cell deformability
Huang, Z., Louderback, J. G., King, S. B., Ballas, S. K., & Kim‐Shapiro, D. B. (2001) · American Journal of Hematology · doi:10.1002/ajh.1098 · Cited by 21
“The primary cause of the disease is the presence of a mutant form ( b6 glu→val) of hemoglobin (Hb S) [2].”
Part 3: Sickle Cell Anaemia in Tropical Africa
Luzzatto, L. (1981) · Clinics in Haematology · doi:10.1016/s0308-2261(21)00298-8 · Cited by 26
A Comparison of Fragments of Rabbit Antibodies and Normal γ-Globulin by the Peptide-Map Technique*
Givol, D., & Sela, M. (1964) · Biochemistry · doi:10.1021/bi00891a025 · Cited by 21
BIOCHEMICAL GENETICS OF THE PRIMATES‐HEMOGLOBINS AND TRANSFERRINS*
Buettner‐Janusch, J. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb13642.x · Cited by 21
Some Aspects of the Chemistry and Function of Human and Animal Hemoglobins
Schroeder, W. A., & Jones, R. T. (1965) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-7139-4_4 · Cited by 21
An appraisal of radioiodination methods for peptide mapping
Davison, P. F. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90063-4 · Cited by 21
Chemical and Immunological Comparisons of Allelic Immobilization Antigens in Paramecium aurelia
Jones, I. G., & Beale, G. H. (1963) · Nature · doi:10.1038/197205b0 · Cited by 21
Buettner‐Janusch, J., & Buettner‐Janusch, V. (1964) · Elsevier eBooks · doi:10.1016/b978-0-12-395562-3.50008-4 · Cited by 21
Principles of Molecular Disease: Lessons from the Hemoglobinopathies
Nussbaum, R. L., McInnes, R. R., Willard, H. F., & Hamosh, A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3080-5.50014-6 · Cited by 21
The Molecular Basis of Evolution and Disease: A Cold War Alliance
Suárez‐Díaz, E. (2017) · Journal of the History of Biology · doi:10.1007/s10739-017-9476-9 · Cited by 21
Roberto, C., Yeh, H., & Soo, V. (2011) · InTech eBooks · doi:10.5772/20049 · Cited by 23
A survey of perioperative management of sickle cell disease in North America
Firth, P. G., McMillan, K. N., Haberkern, C. M., Yaster, M., Bender, M. A., & Goodwin, S. R. (2010) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2010.03415.x · Cited by 20
The management of painful crisis in sickle cell disease
Wright, J., & Ahmedzai, S. H. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328339429a · Cited by 20
Linus Pauling's “molecular diseases”: Between history and memory
Strasser, B. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10542 · Cited by 22
“He called his method ‘‘fingerprinting’’ [ Ingram, 1956, 1957 ].”
Targeting novel mechanisms of pain in sickle cell disease
Tran, H., Gupta, M., & Gupta, K. (2017) · Hematology · doi:10.1182/asheducation-2017.1.546 · Cited by 22
“SCD is an autosomal recessive disorder caused by substitution of a valine residue for glutamic acid at position 6 in b-globin, resulting in sickle hemoglobin (HbS).(4) A unique feature of SCD is vaso-occlusive crises (VOCs) characterized by episodic, recurrent, and unpredictable episodes of acute pain.”
BackgroundOn the Binding Free Energy and Molecular Origin of Sickle Cell Hemoglobin Aggregation
Galamba, N., & Pipolo, S. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b03708 · Cited by 20
Detterich, J. A., Liu, H., Suriany, S., Kato, R. M., Chalacheva, P., Tedla, B. A., Shah, P., Khoo, M. C. K., Wood, J. C., Coates, T. D., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.004 · Cited by 20
Effects of a Single Sickling Event on the Mechanical Fragility of Sickle Cell Trait Erythrocytes
Presley, T. D., Perlegas, A. S., Bain, L. E., Ballas, S. K., Nichols, J. S., Sabio, H., Gladwin, M. T., Kato, G. J., & Kim‐Shapiro, D. B. (2010) · Hemoglobin · doi:10.3109/03630260903546999 · Cited by 22
“acid by valine at the β6 position (1).”
BackgroundA Recombinant Sickle Hemoglobin Triple Mutant with Independent Inhibitory Effects on Polymerization
Himanen, J., Mirza, U. A., Chait, B. T., Bookchin, R. M., & Manning, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25152 · Cited by 20
Heterogeneity of Thalassemia Major
Wolff, J. A. (1963) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1963.02080040236002 · Cited by 20
Prenatal diagnosis and carrier detection of genetic diseases by analysis of deoxyribonucleic acid
D, H. O. M., & Hejtmancik, J. F. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80682-6 · Cited by 20
Studies on the structure of collagen
Rosmus, J., Deyl, Z., & Drake, M. P. (1967) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(67)90524-7 · Cited by 19
Protein-Mapping, Schnell-Dialyse und Molekulargewichtsbestimmung im Mikrogramm-Bereich
Stegemann, H. (1970) · Fresenius Zeitschrift für Analytische Chemie · doi:10.1007/bf00546375 · Cited by 20
A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients
Soltani, S., Zakeri, A., Tabibzadeh, A., Zandi, M., Ershadi, E., Rezayat, S. A., Khaseb, S., Zakeri, A. M., Nakhaei, M. A., Afzali, S., et al. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00284-x · Cited by 20
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 24
“However, in contrast to β-thalassemia, SCD is caused by a single T→A substitution leading to the translation of valine instead of glutamic acid at position 6 of the β-globin chain (Ingram, 1956; Murayama, 1967).”
BackgroundFilho, A. C. B., Silveira, L., Yanai, A. L. S., & Fernandes, A. B. (2014) · Lasers in Medical Science · doi:10.1007/s10103-014-1635-z · Cited by 19
Cui, M., Xiao, X., Zhao, M., & Zheng, B. (2017) · The Analyst · doi:10.1039/c7an00875a · Cited by 19
Sedimentation Characteristics of the γ-Chain Hæmoglobin (Hæmoglobin ‘Bart's’)
Kekwick, R. A., & Lehmann, H. (1960) · Nature · doi:10.1038/187158a0 · Cited by 19
Nitric oxide and sickle cell disease—Is there a painful connection?
Hallmark, L., Almeida, L. E. F., Kamimura, S., Smith, M. L., & Quezado, Z. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220976397 · Cited by 22
“The disease is caused by a single point mutation in the gene encoding the b globin subunit, which results in the expression of a mutant sickle hemoglobin (HbS).(3,4) Upon red blood cell deoxygenation and/or dehydration, HbS polymerizes, which leads to sickling of red blood cells, ongoing chronic hemolysis, and recurre…”
BackgroundPei, W., Li, Y., Wu, Y., Wu, Y., Cai, L., Wang, S., Wang, S., & Chen, J. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308117 · Cited by 18
Katta, V., O’Keefe, K., Li, Y., Mayuranathan, T., Lazzarotto, C. R., Wood, R. K., Levine, R. M., Powers, A., Mayberry, K. D., Manquen, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.022 · Cited by 22
Metastable Mesoscopic Phases in Concentrated Protein Solutions
Vekilov, P. G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.04318.x · Cited by 19
“This is a genetic disease caused by a single mutation from glutamate to valine at the sixth site of the hemoglobin β chain [ 21 ], resulting in abnormal hemoglobin, HbS [22].”
BackgroundHarteveld, C. L., Ponjee, G. A. E., Bakker‐Verweij, M., Arkesteijn, S. G. J., Phylipsen, M., & Giordano, P. (2012) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2012.01424.x · Cited by 18
Hemoglobin polymorphisms in Atlantic cod – A review of 50years of study
Andersen, Ø. (2012) · Marine Genomics · doi:10.1016/j.margen.2012.03.005 · Cited by 18
Ikuta, T., Thatte, H. S., Tang, J. X., Mukerji, I., Knee, K. M., Bridges, K. R., Wang, S., Montero-Huerta, P., Joshi, R. M., & Head, C. A. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.03.013 · Cited by 18
[21] Structural characterization of modified hemoglobins
Jones, R. T. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)31023-8 · Cited by 18
Desforges, J. F., & Wang, M. Y. F. W. (1966) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33102-9 · Cited by 19
The sulphydryl groups of sickle-cell haemoglobin
Ingram, V. M. (1957) · Biochemical Journal · doi:10.1042/bj0650760 · Cited by 18
Self-citationIndicators of susceptibility to industrial chemicals.
Wc, C. (1973) · PubMed · Cited by 18
Étude de l'action du chlorure de sodium sur l'oxyhémoglobine
Benhamou, N., Daune, M. P., Jacob, M., Luzzati, B., & Weill, G. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)90071-8 · Cited by 18
Kit, S. (1960) · PubMed · Cited by 18
Mutationsvorg�nge bei der Entstehung von H�moglobinvarianten
Vogel, F., & R�hrborn, G. (1966) · Human Genetics · doi:10.1007/bf00281051 · Cited by 18
Kim, K. T., & Winssinger, N. (2020) · Chemical Science · doi:10.1039/d0sc00741b · Cited by 17
Biochemical Genetics and Molecular Biology: The Contributions of George Beadle and Edward Tatum
Strauss, B. S. (2016) · Genetics · doi:10.1534/genetics.116.188995 · Cited by 20
“…amino acid sequence was fixed and that this primary protein structure was crucial, it was Vernon Ingram who demonstrated the ability of a single mutation to change a single amino acid in the primary sequence, thereby resulting in a protein with different and pathogenic properties (Ingram 1956).”
BackgroundMikobi, T. M., Lukusa-Tshilobo, P., Aloni, M. N., Lumaka, A. Z., Akilimali, P. Z., Devriendt, K., Matthijs, G., Muamba, J. M., & Race, V. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22186 · Cited by 17
Missense mutations resulting in type 1 lissencephaly
Reiner, O., & Coquelle, F. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4344-0 · Cited by 17
Ghatpande, S. S., Choudhary, P. K., Quinn, C. T., & Goodman, S. R. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.11.003 · Cited by 17
“At the amino acid level, this results in the substitution of glutamic acid by valine in the β-globin subunit of hemoglobin [1].”
BackgroundThe antigenic components of Erysipelothrix rhusiopathiae
White, T. G., & Kalf, G. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90176-x · Cited by 17
Activation analysis of mono- and oligonucleotides
Rushizky, G. W., & Miller, W. W. (1967) · Analytical Biochemistry · doi:10.1016/0003-2697(67)90276-x · Cited by 17
Kubo, S., Tokuyama, H., & Tonomura, Y. (1965) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(65)90016-4 · Cited by 17
Strategy and Methods of Sequence Analysis
Konigsberg, W. H., & Steinman, H. M. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-516303-3.50006-3 · Cited by 18
Cilia proteins are biomarkers of altered flow in the vasculature
Gupta, A., Thirugnanam, K., Thamilarasan, M., Mohieldin, A. M., Zedan, H. T., Prabhudesai, S. N., Griffin, M. A., Spearman, A. D., Pan, A., Palecek, S. P., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.151813 · Cited by 20
“SCD is caused by a single mutation in the β-globin gene that changes the sixth amino acid in the β-globin protein of hemoglobin from glutamic acid to valine (31), which makes RBCs highly susceptible to sickling due to the production of sickle hemoglobin (Hb S) and thus impairs Hb capacity to deliver oxygen to”
Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
Soussi, T., & Baliakas, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.808886 · Cited by 17
Guindo, A., Traoré, K., Diakité, S. A. S., Wellems, T. E., Doumbo, O. K., & Diallo, D. A. (2011) · American Journal of Hematology · doi:10.1002/ajh.22093 · Cited by 16
“SCT is a heterozygous genetic condition resulting from a single point mutation in the gene for the beta chain of hemoglobin (hemoglobin S, HbS), by which an encoded glutamate at position six is replaced with valine [1,2].”
BackgroundDifferential expression of red cell proteins in hemoglobinopathy
Chakrabarti, A., Bhattacharya, D., Basu, A., Basu, S., Saha, S., & Halder, S. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000063 · Cited by 16
“A point mutation in the b-globin gene on chromosome 11 replacing thymine with an adenine causes a single amino acid substitution replacing valine for glutamic acid in residue 6 of b-globin [63].”
BackgroundTranscranial Doppler in hemoglobin SC disease
Vieira, C., de Oliveira, C. N. C., de Figueiredo, L. A. B., Santiago, R. P., Adanho, C. S. A., Santana, S. S., Burak, C. L., Lyra, I. M., & Gonçalves, M. D. S. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26342 · Cited by 16
Recent advances in “sickle and niche” research - Tribute to Dr. Paul S Frenette -
Torres, L. S., Asada, N., Weiss, M. J., Trumpp, A., Suda, T., Scadden, D. T., & Ito, K. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.06.004 · Cited by 19
“The most common and severe form of SCD, sickle cell anemia, is the result of a homozygous mutation in the b-globin gene, and the consequent production of the abnormal tetramer hemoglobin S (a2b S 2, HbS) (Bunn, 1997; Ingram, 1956, 1957; Pauling et al., 1949).”
BackgroundKang, B., Park, K., Kleinhenz, J., Murphy, T. C., Sutliff, R. L., Archer, D. R., & Hart, C. M. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0166oc · Cited by 19
“Taken together, these findings led us to postulate in the current study that: (1) chronic hemolysis in SCD stimulates loss of PPARg and increased expression of the proliferative mediator, ET-1, which contributes to PH pathogenesis; and (2) targeting PPARg with existing pharmacological ligands may represent a novel the…”
BackgroundResultInfluentialSickle Cell Anemia: Reexamining the First "Molecular Disease"
Feldman, S. D., & Tauber, A. I. (1997) · Bulletin of the history of medicine · doi:10.1353/bhm.1997.0178 · Cited by 16
Crystal Structure of Deoxy-Human Hemoglobin β6 Glu → Trp
Harrington, D. J., Adachi, K., & Royer, W. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32690 · Cited by 16
The Genetical Control of Protein Structure: The Abnormal Human Haemoglobins
Hunt, J. A., & Ingram, V. M. (1959) · Novartis Foundation symposium · doi:10.1002/9780470719152.ch9 · Cited by 16
Self-citationvan Tets, P., & Cowan, I. M. (1966) · Canadian Journal of Zoology · doi:10.1139/z66-062 · Cited by 16
Online Biomedical Resources for Malaria‐Related Red Cell Disorders
Piel, F. B., Howes, R. E., Nyangiri, O. A., Moyes, C. L., Williams, T., Weatherall, D. J., & Hay, S. I. (2013) · Human Mutation · doi:10.1002/humu.22330 · Cited by 16
“SCA (MIM #603903) was the first disease linked to the hemoglobin protein [Pauling et al., 1949] and genetically characterized [Ingram, 1956].”
BackgroundLocus-Specific Databases in Cancer: What Future in a Post-Genomic Era? The TP53 LSDB paradigm
Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22518 · Cited by 17
“Using protein sequencing, Vernon Ingram was the first to discover that a small change in the hemoglobin protein could lead to human sickle-cell anemia [Ingram, 1956].”
MethodThe Relationship between ALA16VAL Single Gene Polymorphism and Renal Cell Carcinoma
Atılgan, D., Parlaktaş, B. S., Uluocak, N., Kölükçü, E., Erdemır, F., Özyurt, H., & Erkorkmaz, Ü. (2014) · Advances in Urology · doi:10.1155/2014/932481 · Cited by 15
Detterich, J. A. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189006 · Cited by 18
“Sickle cell disease (SCD) stems from a single base pair mutation in the beta-globin gene, converting the sixth amino acid, glutamic acid, to valine [38].”
CRISPR in Sub-Saharan Africa: Applications and Education
Ogaugwu, C., Agbo, S. O., & Adekoya, M. A. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.07.012 · Cited by 16
Does structural and chemical divergence play a role in precluding undesirable protein interactions?
Jiménez, J. L. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20448 · Cited by 16
Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells
Chang, T., Kakhniashvili, D. G., & Goodman, S. R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20351 · Cited by 16
Himanen, J., Schneider, K., Chait, B. T., & Manning, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13885 · Cited by 15
Russu, I. M., & Ho, C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6577 · Cited by 15
Methodological Issues in Molecular Genetic Studies of Mental Disorders
Bearden, C. E., Jasinska, A. J., & Freimer, N. B. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153545 · Cited by 16
GWAS to Therapy by Genome Edits?
Hardison, R. C., & Blobel, G. A. (2013) · Science · doi:10.1126/science.1245813 · Cited by 15
Molecular phylogenetics before sequences
Ragan, M. A., Bernard, G., & Chan, C. X. (2014) · RNA Biology · doi:10.4161/rna.27505 · Cited by 15
“As we mention above in the context of primary-structural determination, peptides from protease digests could be separated in two dimensions by paper chromatography and electrophoresis, and compared by eye for similarities and differences.(22,45,46)”
MethodDental Complications of Sickle Cell Disease
Ballas, S. K. (2014) · JBR Journal of Interdisciplinary Medicine and Dental Science · doi:10.4172/2376-032x.1000152 · Cited by 15
“This change, in turn, results in replacement of the normal glutamic acid with valine at position 6 of the β-globin chain and the formation of sickle Hb (βsβs) [1-3].”
BackgroundRivers, A. E., Jagadeeswaran, R., & Lavelle, D. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2017 · Cited by 14
Silva, J. T. D., Letzen, J. E., Haythornthwaite, J. A., Finan, P. H., Campbell, C. M., & Seminowicz, D. A. (2019) · Pain · doi:10.1097/j.pain.0000000000001591 · Cited by 17
Effective therapies for sickle cell disease: are we there yet?
Crossley, M., Christakopoulos, G. E., & Weiss, M. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.07.003 · Cited by 22
Candidate Gene and Genome-Wide Association Studies in Behavioral Medicine
Nolte, I. M., McCaffery, J. M., & Snieder, H. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_29 · Cited by 14
“Variation in a single gene is responsible for Mendelian disorders such as cystic fibrosis and sickle cell disease (Ingram, 1956; Riordan et al, 1989).”
BackgroundDecreased thrombin activity by a Congolese herbal medicine used in sickle cell anemia
Nsimba, M. M., Nzunzu, J. L., Hayakawa, Y., Yamamoto, C., & Kaji, T. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.038 · Cited by 13
“The disease is characterized by chronic hemolytic anemia accompanied often with fever, infections and unpredicted painful crises due to vaso-occlusion of sickle erythrocytes trapped in small vessels (Pauling et al., 1949; Ingram, 1956; Murayama and Nalbandian, 1973).”
BackgroundMahmud, Z., Malik, S. U. F., Ahmed, J., & Azad, A. K. (2016) · BioMed Research International · doi:10.1155/2016/2023803 · Cited by 14
IL1A rs1800587 Associates with Chronic Noncrisis Pain in Sickle Cell Disease
Hu, X., Jhun, E. H., Yao, Y., He, Y. Z., Molokie, R. E., Wilkie, D. J., & Wang, Z. J. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0085 · Cited by 14
INCREASED METABOLIC HEAT PRODUCTION BY ERYTHROCYTES IN SICKLE-CELL DISEASE
Boyo, A. E., & Ikomi-Kumm, J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90929-4 · Cited by 15
Covalent Inhibitors of the Gelation of Sickle Cell Hemoglobin and Their Effects on Function
Manning, J. M. (1991) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123102.ch2 · Cited by 14
Étude de l'action du chlorure de sodium sur l'oxyhémoglobine
Benhamou, N., & Weill, G. (1957) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(57)90245-7 · Cited by 14
Xue, L., Wang, F., Xiong, L., Du, R., Zhou, H.-L., Zou, Y., Wu, M., Yang, M., Dai, J., He, M., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.001 · Cited by 14
“The extensive human diseases such as β-thalassemia, sickle-cell anemia and cystic fibrosis were caused by SNPs (Ingram, 1956; Chang and Kan, 1979; Hamosh et al., 1992).”
BackgroundIntegrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence
Sagi, V., Argueta, D. A., Kiven, S. B., & Gupta, K. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102394 · Cited by 13
Updated mechanisms underlying sickle cell disease-associated pain
Du, S., Lin, C., & Tao, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134471 · Cited by 13
Song, A., Wen, A. Q., Wen, Y. E., Dzieciątkowska, M., Kellems, R. E., Juneja, H. S., D’Alessandro, A., & Xia, Y. (2022) · The FASEB Journal · doi:10.1096/fj.202101500rr · Cited by 12
Metadata
- Authors
- INGRAM, V. M.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- INGRAM, V. M.
- Venue
- Nature
- Published
- 1956-10
- Volume
- 178
- Issue
- 4537
- Pages
- 792-794
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2089819802
- Cited by
- 896
- References
- 12
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 24 · 2023: 26 · 2022: 41 · 2021: 22 · 2020: 17 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 30 · 2015: 19 · 2014: 25 · 2013: 26 · 2012: 17
- FWCI
- 29.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- globin, sickle cell disease, hemoglobin, hemoglobin structure, hemoglobinopathies
- MeSH terms
- Anemia, Anemia, Sickle Cell, Globins, Hemoglobins, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.